Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

VDR gene variations may affect carbohydrate metabolism in young women with hyperandrogenism.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

Early identification of lupus through skin signs and blood tests is crucial in India.

Hormonal treatments effectively manage acne in some women, especially with specific hormonal issues.

The article concludes that hormonal therapy is an effective long-term acne treatment, even for those without hormonal imbalances.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Biomedical engineers are crucial for developing better treatments for chronic and autoimmune diseases.

Managing oxidative stress and inflammation is crucial for better hair transplant results.

Adiponectin and bradykinin play important roles in skin health and may help treat skin conditions.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Adults with certain skin conditions may have higher levels of inflammation in their body.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Late onset SLE has different symptoms and antibody profiles compared to young onset SLE.

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.